{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T02:03:37Z","timestamp":1790042617127,"version":"4.0.1"},"reference-count":63,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T00:00:00Z","timestamp":1663804800000},"content-version":"am","delay-in-days":356,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100010457","name":"Centre Hospitalier Universitaire de Bordeaux","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010457","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.revmed.2021.03.003","type":"journal-article","created":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T19:41:48Z","timestamp":1617738108000},"page":"714-721","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Scl\u00e9rose tub\u00e9reuse de Bourneville\u00a0: mise au point"],"prefix":"10.1016","volume":"42","author":[{"given":"P.","family":"Pfirmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Combe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Rigothier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2021.03.003_bib0320","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1136\/jmg.26.1.28","article-title":"Genetic aspects of tuberous sclerosis in the west of Scotland","volume":"26","author":"Sampson","year":"1989","journal-title":"J Med Genet"},{"key":"10.1016\/j.revmed.2021.03.003_bib0325","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0140-6736(05)60291-7","article-title":"Prevalence of tuberous sclerosis in UK","volume":"352","author":"Morrison","year":"1998","journal-title":"The Lancet"},{"key":"10.1016\/j.revmed.2021.03.003_bib0330","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0387-7604(81)80007-1","article-title":"Frequency of tuberous sclerosis in san-in district (Japan) and birth weight of patients with tuberous sclerosis","volume":"3","author":"Ohno","year":"1981","journal-title":"Brain and Development"},{"key":"10.1016\/j.revmed.2021.03.003_bib0335","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/S0140-6736(05)78872-3","article-title":"Prevalence of tuberous sclerosis estimated by capture-recapture analysis","volume":"351","author":"O\u2019Callaghan","year":"1998","journal-title":"The Lancet"},{"key":"10.1016\/j.revmed.2021.03.003_bib0340","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S0025-6196(12)61196-3","article-title":"Causes of death in patients with tuberous sclerosis","volume":"66","author":"Shepherd","year":"1991","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.revmed.2021.03.003_bib0345","first-page":"612","article-title":"Causes of mortality in individuals with tuberous sclerosis complex","volume":"59","year":"2017","journal-title":"Child Neurology"},{"key":"10.1016\/j.revmed.2021.03.003_bib0350","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13023-016-0553-5","article-title":"TuberOus SClerosis registry to increase disease Awareness (TOSCA)\u2013baseline data on 2093\u00a0patients","volume":"12","author":"Kingswood","year":"2017","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.revmed.2021.03.003_bib0355","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1126\/science.277.5327.805","article-title":"Identification of the tuberous sclerosis gene TSC1\u00a0on chromosome 9q34","volume":"277","author":"van Slegtenhorst","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.revmed.2021.03.003_bib0360","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/0092-8674(93)90618-Z","article-title":"European chromosome 16\u00a0tuberous sclerosis consortium. Identification and characterization of the tuberous sclerosis gene on chromosome 16","volume":"75","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.revmed.2021.03.003_bib0365","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0140-6736(95)90213-9","article-title":"Somatic mosaicism and clinical variation in tuberous sclerosis complex","volume":"345","author":"Verhoef","year":"1995","journal-title":"The Lancet"},{"key":"10.1016\/j.revmed.2021.03.003_bib0370","doi-asserted-by":"crossref","first-page":"e1005637","DOI":"10.1371\/journal.pgen.1005637","article-title":"Mosaic and intronic mutations in TSC1\/TSC2\u00a0explain the majority of tsc patients with no mutation identified by conventional testing","volume":"11","author":"Tyburczy","year":"2015","journal-title":"PLoS Genet"},{"key":"10.1016\/j.revmed.2021.03.003_bib0375","doi-asserted-by":"crossref","first-page":"4456","DOI":"10.1038\/s41598-019-38898-9","article-title":"Whole exome sequencing identifies a novel intron heterozygous mutation in TSC2\u00a0responsible for tuberous sclerosis complex","volume":"9","author":"Ye","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.revmed.2021.03.003_bib0380","doi-asserted-by":"crossref","first-page":"15816","DOI":"10.1038\/ncomms15816","article-title":"The genomic landscape of tuberous sclerosis complex","volume":"8","author":"Martin","year":"2017","journal-title":"Nature Com"},{"key":"10.1016\/j.revmed.2021.03.003_bib0385","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1177\/088307389801301206","article-title":"Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria","volume":"13","author":"Roach","year":"1998","journal-title":"J Child Neurol"},{"key":"10.1016\/j.revmed.2021.03.003_bib0390","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.pediatrneurol.2013.08.002","article-title":"Tuberous sclerosis complex surveillance and management: recommendations of the 2012\u00a0international tuberous sclerosis complex consensus conference","volume":"49","author":"Krueger","year":"2013","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.revmed.2021.03.003_bib0395","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(08)61279-9","article-title":"Tuberous sclerosis","volume":"372","author":"Curatolo","year":"2008","journal-title":"The Lancet"},{"key":"10.1016\/j.revmed.2021.03.003_bib0400","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1749-6632.1991.tb37743.x","article-title":"Neuropsychiatric aspects of tuberous sclerosis","volume":"615","author":"Curatolo","year":"1991","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.revmed.2021.03.003_bib0405","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/epi4.12286","article-title":"Epilepsy in tuberous sclerosis complex: findings from the TOSCA study","volume":"4","author":"Nabbout","year":"2019","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.revmed.2021.03.003_bib0410","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/j.wneu.2018.06.169","article-title":"Subependymal giant cell astrocytoma: a surveillance, epidemiology, and end results program\u2013based analysis from 2004\u00a0to 2013","volume":"118","author":"Nguyen","year":"2018","journal-title":"World Neurosurgery"},{"key":"10.1016\/j.revmed.2021.03.003_bib0415","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1468-1331.2009.02567.x","article-title":"Prevalence of subependymal giant cell tumors in patients with tuberous sclerosis and a review of the literature","volume":"16","author":"Adriaensen","year":"2009","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.revmed.2021.03.003_bib0420","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.pediatrneurol.2014.10.004","article-title":"Tuberous Sclerosis Associated Neuropsychiatric Disorders (TAND) and the TAND Checklist","volume":"52","author":"de Vries","year":"2015","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.revmed.2021.03.003_bib0425","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s13023-018-0901-8","article-title":"TSC-associated neuropsychiatric disorders (TAND): findings from the TOSCA natural history study","volume":"13","author":"de Vries","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.revmed.2021.03.003_bib0430","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/j.1464-410X.2004.05046.x","article-title":"An epidemiological study of renal pathology in tuberous sclerosis complex","volume":"94","author":"O\u2019Callaghan","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.revmed.2021.03.003_bib0435","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1177\/0300060519834447","article-title":"Renal function, complications, and outcomes of a reduction in tumor size after transarterial embolization for renal angiomyolipomas: a meta-analysis","volume":"47","author":"Lin","year":"2019","journal-title":"J Int Med Res"},{"key":"10.1016\/j.revmed.2021.03.003_bib0440","article-title":"Description of a multidisciplinary model of care in a French cohort of adult patients with tuberous sclerosis complex","author":"Pfirmann","year":"2020","journal-title":"J Med Genet"},{"key":"10.1016\/j.revmed.2021.03.003_bib0445","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s00261-014-0083-3","article-title":"Renal angiomyolipoma: a radiological classification and update on recent developments in diagnosis and management","volume":"39","author":"Jinzaki","year":"2014","journal-title":"Abdom Imaging"},{"key":"10.1016\/j.revmed.2021.03.003_bib0450","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1016\/S0022-5347(17)35895-0","article-title":"The natural history of renal angiomyolipoma","volume":"150","author":"Steiner","year":"1993","journal-title":"J Urol"},{"key":"10.1016\/j.revmed.2021.03.003_bib0455","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1148\/radiol.2251011477","article-title":"Renal angiomyolipoma: relationships between tumor size, aneurysm formation, and rupture","volume":"225","author":"Yamakado","year":"2002","journal-title":"Radiology"},{"key":"10.1016\/j.revmed.2021.03.003_bib0460","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1177\/1756287216641353","article-title":"Optimal treatment of tuberous sclerosis complex associated renal angiomyolipomata: a systematic review","volume":"8","author":"Bissler","year":"2016","journal-title":"Ther Adv Urol"},{"key":"10.1016\/j.revmed.2021.03.003_bib0465","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1136\/jmg.33.6.480","article-title":"A cross sectional study of renal involvement in tuberous sclerosis","volume":"33","author":"Cook","year":"1996","journal-title":"J Med Genet"},{"key":"10.1016\/j.revmed.2021.03.003_bib0470","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1038\/sj.ki.5001853","article-title":"Renal manifestations of tuberous sclerosis complex: incidence, prognosis, and predictive factors","volume":"70","author":"Rakowski","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.revmed.2021.03.003_bib0475","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.yebeh.2007.07.010","article-title":"Psychiatric comorbid conditions in a clinic population of 241\u00a0patients with tuberous sclerosis complex","volume":"11","author":"Muzykewicz","year":"2007","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.revmed.2021.03.003_bib0480","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2133.1996.d01-923.x","article-title":"The cutaneous features of tuberous sclerosis: a population study","volume":"135","author":"Webb","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.revmed.2021.03.003_bib0485","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1136\/adc.2011.211995","article-title":"The tuberous sclerosis 2000\u00a0study: presentation, initial assessments and implications for diagnosis and management","volume":"96","author":"Yates","year":"2011","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.revmed.2021.03.003_bib0490","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1093\/hmg\/ddt597","article-title":"Sun exposure causes somatic second-hit mutations and angiofibroma development in tuberous sclerosis complex","volume":"23","author":"Tyburczy","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.revmed.2021.03.003_bib0495","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1046\/j.1365-4362.1998.00495.x","article-title":"Skin lesions in children with tuberous sclerosis complex: their prevalence, natural course, and diagnostic significance","volume":"37","author":"J\u00f3\u017awiak","year":"1998","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.revmed.2021.03.003_bib0500","doi-asserted-by":"crossref","first-page":"e507","DOI":"10.1111\/jdv.14357","article-title":"The molluscum pendulum necklace sign in tuberous sclerosis complex: a case series A pathognomonic finding?","volume":"31","author":"Sachs","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.revmed.2021.03.003_bib0505","doi-asserted-by":"crossref","first-page":"e144","DOI":"10.1111\/jdv.14627","article-title":"More about molluscum pendulum\/acrochordons in tuberous sclerosis complex","volume":"32","author":"Lipsker","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.revmed.2021.03.003_bib0510","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1001\/archderm.1962.01590020049006","article-title":"Special reference to the microscopic alterations in the cutaneous hamartomas","volume":"85","author":"Nickel","year":"1962","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.revmed.2021.03.003_bib0515","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.crad.2011.02.009","article-title":"Radiological evidence of lymphangioleiomyomatosis in female and male patients with tuberous sclerosis complex","volume":"66","author":"Adriaensen","year":"2011","journal-title":"Clin Radiol"},{"key":"10.1016\/j.revmed.2021.03.003_bib0520","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.rmed.2012.07.007","article-title":"Cystic lung disease is not uncommon in men with tuberous sclerosis complex","volume":"106","author":"Ryu","year":"2012","journal-title":"Respir Med"},{"key":"10.1016\/j.revmed.2021.03.003_bib0525","doi-asserted-by":"crossref","first-page":"e1146","DOI":"10.1542\/peds.2006-0504","article-title":"Clinical and genotype studies of cardiac tumors in 154\u00a0patients with tuberous sclerosis complex","volume":"118","author":"Jozwiak","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.revmed.2021.03.003_bib0530","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1177\/1120672118787441","article-title":"Optic coherence tomography appearances of retinal astrocytic hamartoma and systemic features in tuberous sclerosis of Japanese patients","volume":"29","author":"Kato","year":"2018","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.revmed.2021.03.003_bib0535","doi-asserted-by":"crossref","DOI":"10.1016\/j.urology.2016.10.056","article-title":"Assessment of tuberous sclerosis complex associated with renal lesions by targeted next-generation sequencing in mainland China","volume":"101","author":"Cai","year":"2017","journal-title":"Urology"},{"key":"10.1016\/j.revmed.2021.03.003_bib0540","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/s41598-018-19399-7","article-title":"Sclerotic bone lesions as a potential imaging biomarker for the diagnosis of tuberous sclerosis complex","volume":"8","author":"Brakemeier","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.revmed.2021.03.003_bib0545","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.pediatrneurol.2017.09.012","article-title":"Liver angiomyolipomas in tuberous sclerosis complex-their incidence and course","volume":"78","author":"J\u00f3\u017awiak","year":"2018","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.revmed.2021.03.003_bib0550","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/GIM.0b013e31803068c7","article-title":"Genotype\/phenotype correlation in 325\u00a0individuals referred for a diagnosis of tuberous sclerosis complex in the United States","volume":"9","author":"Au","year":"2007","journal-title":"Genet Med"},{"key":"10.1016\/j.revmed.2021.03.003_bib0555","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/sj.ejhg.5201402","article-title":"Mutational analysis of the TSC1\u00a0and TSC2\u00a0genes in a diagnostic setting: genotype\u2013phenotype correlations and comparison of diagnostic DNA techniques in tuberous sclerosis complex","volume":"13","author":"Sancak","year":"2005","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.revmed.2021.03.003_bib0560","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13023-019-1072-y","article-title":"A step-wise approach for establishing a multidisciplinary team for the management of tuberous sclerosis complex: a Delphi consensus report","volume":"14","author":"Auvin","year":"2019","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.revmed.2021.03.003_bib0565","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0140-6736(12)61767-X","article-title":"Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial","volume":"381","author":"Bissler","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2021.03.003_bib0570","doi-asserted-by":"crossref","first-page":"e0180939","DOI":"10.1371\/journal.pone.0180939","article-title":"Everolimus long-term use in patients with tuberous sclerosis complex: four-year update of the EXIST-2\u00a0study","volume":"12","author":"Bissler","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.revmed.2021.03.003_bib0575","doi-asserted-by":"crossref","first-page":"e0201005","DOI":"10.1371\/journal.pone.0201005","article-title":"Angiomyolipoma rebound tumor growth after discontinuation of everolimus in patients with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis","volume":"13","author":"Bissler","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.revmed.2021.03.003_bib0580","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1053\/j.ajkd.2005.09.028","article-title":"Embolization of renal angiomyolipomata in patients with tuberous sclerosis complex","volume":"47","author":"Williams","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.revmed.2021.03.003_bib0585","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1053\/ajkd.2002.32770","article-title":"Reduction of postembolization syndrome after ablation of renal angiomyolipoma","volume":"39","author":"Bissler","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.revmed.2021.03.003_bib0590","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1053\/j.ajkd.2015.05.016","article-title":"Long-term follow-up assessing renal angiomyolipoma treatment patterns, morbidity, and mortality: an observational study in tuberous sclerosis complex patients in the Netherlands","volume":"66","author":"Eijkemans","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.revmed.2021.03.003_bib0595","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1016\/S0140-6736(16)31419-2","article-title":"Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study","volume":"388","author":"French","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2021.03.003_bib0600","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1056\/NEJMoa1001671","article-title":"Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis","volume":"363","author":"Krueger","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2021.03.003_bib0605","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(12)61134-9","article-title":"Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3\u00a0trial","volume":"381","author":"Franz","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2021.03.003_bib0610","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S1470-2045(14)70489-9","article-title":"Everolimus for subependymal giant cell astrocytoma in patients with tuberous sclerosis complex: 2-year open-label extension of the randomised EXIST-1\u00a0study","volume":"15","author":"Franz","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.revmed.2021.03.003_bib0615","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1002\/acn3.494","article-title":"Everolimus for treatment of tuberous sclerosis complex-associated neuropsychiatric disorders","volume":"4","author":"Krueger","year":"2017","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.revmed.2021.03.003_bib0620","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1056\/NEJMoa1100391","article-title":"Efficacy and safety of sirolimus in lymphangioleiomyomatosis","volume":"364","author":"McCormack","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2021.03.003_bib0625","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1111\/jdv.14964","article-title":"Effect of everolimus on skin lesions in patients treated for subependymal giant cell astrocytoma and renal angiomyolipoma: final 4-year results from the randomized EXIST-1\u00a0and EXIST-2\u00a0studies","volume":"32","author":"Franz","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.revmed.2021.03.003_bib0315","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/jamadermatol.2018.1408","article-title":"Sirolimus gel treatment vs. placebo for facial angiofibromas in patients with tuberous sclerosis complex","volume":"154","author":"Wataya-Kaneda","year":"2018","journal-title":"JAMA Dermatol"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866321000618?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866321000618?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:44:02Z","timestamp":1759337042000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866321000618"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":63,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S0248866321000618"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2021.03.003","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Scl\u00e9rose tub\u00e9reuse de Bourneville\u00a0: mise au point","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2021.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}